Hahaha.
And what would be your take on the same former employee telling another well known finance journalist in an interview that the DEP-Docetaxel trial would complete and results announced by end of 2018, only for it to painstakingly drag on for another 5 years?
It would be understandable if some shareholders have felt misled over the journey by some of the statements out of HQ such as this and many others.
Could this happen to Viraleze with marketing approval, page-28
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $62.84K | 565.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10428 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
-0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.5¢ | 11.0¢ | 167020 | ||
| Last updated 15.32pm 24/05/2024 ? | |||||
| SPL (ASX) Chart |